This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tamura, K. Articles by Fukamizu, A. Search for Related Content PubMed PubMed Citation Articles by Tamura, K. Articles by Fukamizu, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Hypertension, Vol 23, 364-368, Copyright © 1994 by American Heart Association

ARTICLES

Molecular mechanism of adipogenic activation of the angiotensinogen gene

K Tamura, S Umemura, T Iwamoto, S Yamaguchi, S Kobayashi, K Takeda, Y Tokita, N Takagi, K Murakami and A Fukamizu
Second Department of Internal Medicine, Yokohama City University School of Medicine, Japan.

Angiotensinogen gene expression is controlled in a tissue- and development-specific manner. Interestingly, the angiotensinogen gene is abundantly expressed in adipose tissues other than the liver, where it is mainly produced. We investigated the molecular mechanism of angiotensinogen gene expression in a 3T3-L1 preadipocyte-adipocyte system. Although angiotensinogen mRNA was barely detectable in preadipocytes, its levels increased significantly during differentiation. As a whole, the pattern of the change in transcriptional activity of the angiotensinogen promoter was similar to that of the angiotensinogen mRNA levels during adipogenic differentiation, indicating that the activation of the angiotensinogen promoter might be involved in the adipogenic differentiation-coupled gene expression. The proximal promoter region, from -96 to +22 of the transcriptional start site, was sufficient to confer adipogenic activation, and the proximal element from -96 to -52 of the transcriptional start site was necessary for this promoter stimulation. DNA-protein binding experiments showed that this proximal element specifically bound to a nuclear factor induced by adipogenic differentiation. These results suggest that the proximal promoter element from -96 to -52 plays a role in adipogenic activation of the angiotensinogen promoter.

This article has been cited by other articles:

				D. Ma, M. F. Feitosa, J. B. Wilk, J. M. Laramie, K. Yu, C. Leiendecker-Foster, R. H. Myers, M. A. Province, and I. B. Borecki Leptin Is Associated With Blood Pressure and Hypertension in Women From the National Heart, Lung, and Blood Institute Family Heart Study Hypertension, March 1, 2009; 53(3): 473 - 479. [Abstract] [Full Text] [PDF]

				K. Rahmouni, A. L. Mark, W. G. Haynes, and C. D. Sigmund Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E891 - E895. [Abstract] [Full Text] [PDF]

				J. Janke, S. Engeli, K. Gorzelniak, F. C. Luft, and A. M. Sharma Mature Adipocytes Inhibit In Vitro Differentiation of Human Preadipocytes via Angiotensin Type 1 Receptors Diabetes, June 1, 2002; 51(6): 1699 - 1707. [Abstract] [Full Text] [PDF]

				I. Hainault, G. Nebout, S. Turban, B. Ardouin, P. Ferre, and A. Quignard-Boulange Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E59 - E66. [Abstract] [Full Text] [PDF]

				V. Serazin-Leroy, M. Morot, P. de Mazancourt, and Y. Giudicelli Androgen regulation and site specificity of angiotensinogen gene expression and secretion in rat adipocytes Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1398 - E1405. [Abstract] [Full Text] [PDF]

				S. Engeli, R. Negrel, and A. M. Sharma Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1270 - 1277. [Abstract] [Full Text] [PDF]

				T. Ishigami, K. Tamura, T. Fujita, I. Kobayashi, K. Hibi, M. Kihara, Y. Toya, H. Ochiai, and S. Umemura Angiotensinogen Gene Polymorphism Near Transcription Start Site and Blood Pressure : Role of a T-to-C Transition at Intron I Hypertension, September 1, 1999; 34(3): 430 - 434. [Abstract] [Full Text] [PDF]

				J. H. Pratt, W. T. Ambrosius, D. A. Tewksbury, M. A. Wagner, L. Zhou, and M. P. Hanna Serum Angiotensinogen Concentration in Relation to Gonadal Hormones, Body Size, and Genotype in Growing Young People Hypertension, November 1, 1998; 32(5): 875 - 879. [Abstract] [Full Text] [PDF]

				N. Nyui, K. Tamura, S. Yamaguchi, M. Nakamaru, T. Ishigami, M. Yabana, M. Kihara, H. Ochiai, N. Miyazaki, S. Umemura, et al. Tissue Angiotensinogen Gene Expression Induced by Lipopolysaccharide in Hypertensive Rats Hypertension, October 1, 1997; 30(4): 859 - 867. [Abstract] [Full Text]

				A. R. Brasier and J. Li Mechanisms for Inducible Control of Angiotensinogen Gene Transcription Hypertension, March 1, 1996; 27(3): 465 - 475. [Abstract] [Full Text]